Board Seeks Near-Total Voting Control and Massive Dilution via Super-Voting Preferred Stock and Expanded Equity Plan

summarizeSummary

Wellgistics Health is seeking shareholder approval for a new class of super-voting preferred stock that would give insiders nearly 96% of voting power, alongside a massive expansion of its equity incentive plan and authorization of 1,000,000 blank check preferred shares, significantly diluting common shareholders and concentrating control.

check_boxKey Events

• Proposed Super-Voting Preferred Stock

  The company is seeking to designate and issue 6,000 shares of Series A Super-Voting Preferred Stock to directors and executive officers. Each share would carry 10,000 votes, effectively granting these insiders approximately 95.78% of the total voting power, thereby concentrating control.

• Massive Equity Incentive Plan Expansion

  Shareholders are asked to approve an amendment to the 2023 Equity Incentive Plan, increasing the maximum annual share reserve increase from 3% to 20% of outstanding common shares. This represents a potential annual dilution of over 529,000 common shares.

• Authorization of Blank Check Preferred Stock

  The board seeks approval to authorize 1,000,000 shares of 'blank check' preferred stock, providing broad authority to issue these shares with various rights and preferences without further shareholder approval, posing substantial future dilution risk.

• Corporate Rebranding

  The company proposes to change its name from 'Wellgistics Health, Inc.' to 'DataMeds AI, Inc.' to better align with a new strategic focus on healthcare technology and pharmaceutical services.

auto_awesomeAnalysis

This filing outlines a series of proposals that, if approved, would fundamentally alter Wellgistics Health's corporate governance and significantly increase potential dilution for common shareholders. The most critical proposal is the creation and issuance of Series A Super-Voting Preferred Stock to directors and executive officers, which would grant them approximately 95.78% of the total voting power with minimal economic investment. This effectively transfers control from common shareholders to a select group of insiders. Additionally, the proposed amendment to the equity incentive plan would allow for an annual increase of up to 20% of outstanding common shares, representing a substantial and ongoing dilutive mechanism. These measures, alongside the authorization of 1,000,000 'blank check' preferred shares, signal a desperate attempt to secure control and financing amidst severe financial distress, a going concern warning, and ongoing Nasdaq delisting threats. The proposed changes effectively disenfranchise common shareholders while providing the board with immense flexibility for future dilutive actions.